Waverley Pharma Inc.
WAVE.V
TSX
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -119.00K | -172.80K | -20.10K | -20.10K | -25.10K |
| Total Depreciation and Amortization | 14.70K | 14.90K | 14.90K | 14.90K | 14.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.20K | 53.20K | -12.80K | -12.80K | 3.60K |
| Change in Net Operating Assets | 36.30K | 3.90K | -31.30K | -31.30K | -105.90K |
| Cash from Operations | -46.80K | -100.80K | -49.40K | -49.40K | -112.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 184.30K |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -152.70K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 31.60K |
| Total Debt Issued | 96.50K | 67.50K | 80.10K | 80.10K | 32.50K |
| Total Debt Repaid | -8.40K | -8.20K | -8.20K | -8.20K | -8.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.30K | 43.00K | 52.00K | 52.00K | 16.60K |
| Foreign Exchange rate Adjustments | 500.00 | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.00K | -57.80K | 2.60K | 2.60K | -64.30K |